Company Filing History:
1 out of 155 
1 out of 583 
1 out of 658 Years Active: 2010
Title: The Innovative Contributions of Jung-Im Kim
Introduction: Jung-Im Kim, an esteemed inventor based in Busan, South Korea, has made significant strides in the field of biochemistry. With a focus on peptide research, he has developed a patented method to inhibit FPR class receptor activity, showcasing his dedication to advancing scientific understanding and therapeutic applications.
Latest Patents: Jung-Im Kim holds a noteworthy patent titled "Peptides that antagonize FPR class receptor mediated signaling." This patent reveals the composition and utility of W-rich peptides, which are designed to inhibit the activity of FPR class receptors. Such innovations hold promise for medical advancements, particularly in inflammatory and immune responses.
Career Highlights: Throughout his career, Jung-Im Kim has been associated with prestigious organizations, including the POSTECH Foundation and POSCO. His work in these institutions has facilitated the growth of his research and the practical application of his innovations in the industry.
Collaborations: Jung-Im Kim has collaborated with notable colleagues, including Pann-Ghill Suh and Yoe-Sik Bae. These partnerships have played a pivotal role in enhancing the scope and impact of his research endeavors.
Conclusion: Jung-Im Kim's innovative contributions, particularly in the realm of peptide research and receptor inhibition, underscore his importance as an inventor. His work not only highlights his individual talents but also emphasizes the collaborative nature of scientific progress, paving the way for future advancements in the field.